DANIELLE THEBERGE: Open Payments
NPI 1609216803 · SURF CITY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$362 in 20 payments from 8 companies in 2025. Trend: 2023 $164 · 2024 $96 · 2025 $362
Food & beverage: $362
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $71 |
| AstraZeneca Pharmaceuticals LP | 3 | $65 |
| Exeltis, USA Inc. | 3 | $59 |
| Novo Nordisk Inc | 3 | $54 |
| Vanda Pharmaceuticals Inc. | 3 | $50 |
| Amgen Inc. | 2 | $31 |
| Exact Sciences Corporation | 1 | $16 |
| Phadia US Inc. | 1 | $16 |
Products named: Veozah, SLYND, BREZTRI, HETLIOZ, Wegovy, Rybelsus, OTEZLA, The Cologuard Plus Collection Kit.
Industry payments across NC — which companies pay providers there.
